At Scripta, we're moving beyond a target-centric mindset to an appreciation that disease mechanisms are complex and often underpinned by transcriptional dysregulation.

Dive into how we’re rethinking drug discovery through the lens of transcription factor biology in a new article featured on the front page of Drug Target Review. It explores how our AI-centric, lab-in-the-loop platform is yielding opportunities to move away from the herd and find truly disease-modifying therapeutics.

To read the article, head here: https://www.drugtargetreview.com/article/192367/rethinking-drug-discovery-through-transcription-factor-biology/